Roivant Sciences

Dermavant CEO draws Botox comparison to instill Vtama confidence

Dermavant CEO Todd Zavodnick isn’t worried about the disappointing uptake of Vtama, saying it will flourish when it is approved for atopic dermatitis.

Kevin Dunleavy Nov 28, 2023 4:10pm

Dermavant's Vtama cream hits goal in first eczema phase 3 study

Mar 15, 2023 11:42am

Dermavant launches first streaming commercial for Vtama

Nov 29, 2022 3:20pm

Moderna faces a patent infringement suit tied to its COVID shot

Feb 28, 2022 9:55am